Recent studies reveal MG53 (TRIM72) enhances muscle stem cell activation and reduces inflammation, offering a novel therapeutic target for sarcopenia with promising preclinical and early clinical resu...
Recent UK Biobank data reveals myostatin variants boosting muscle mass, with research accelerating on combining inhibitors with GLP-1 drugs to combat sarcopenia, highlighting ethical debates in therap...
Exploring recent advances in senolytic and senomorphic therapies, including dasatinib-quercetin and immune-based approaches, to combat age-related diseases like Alzheimer’s and sarcopenia. New t...
Recent studies reveal that supplementing Roseburia inulinivorans enhances muscle strength by up to 30% in mice, with human trials showing promise for probiotic therapies against sarcopenia. New resear...
Recent studies show Roseburia inulinivorans boosts muscle strength in aging, with probiotics targeting sarcopenia gaining traction in the wellness market amid regulatory and ethical debates. Breakthro...
Recent research reveals ferroptosis, an iron-dependent cell death mechanism, as a key factor in age-related muscle loss, with potential therapies targeting lipid peroxidation. A 2023 study in ‘A...
Recent research indicates that upregulating CMA via LAMP2A can reverse muscle atrophy in aging, with potential for new interventions against sarcopenia. Scientists discover CMA enhancement as a key to...
Recent Swedish research shows long-term exposure to PM2.5, PM10, and NOx elevates sarcopenia risk in seniors via chronic inflammation, urging public health interventions for aging populations. A Swedi...
New research reveals heavy resistance training boosts osteocalcin, improving bone density and cognitive function in postmenopausal women more effectively than light training. Heavy weight training tri...
New research identifies four key exercises—pull-ups, split squats, plank-pushups, and farmer’s carries—as critical benchmarks for combating muscle loss, preserving balance, and ensuring long...